`
`Document119_
`
`Filed 04/29/19
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`Page 1 of 5 PagelD #: 14068
`
`
`laintiff:
`
`Plaintiffs,
`
` GENENTECH,INC, and CITY OF HOPE,
`
`
`‘
`
`SAMSUNGBIOEPIS CO., LTD.,
`
`
`Defendant.
`
`
`C.A. No. 18-cv-1363-CFC
`REDACTED PUBLIC VERSION
`
`STIPULATION AND [PROPOSED] ORDER OF DISMISSAL
`WITH RESPECT TO CERTAIN ASSERTED PATENTS AND CITY OF HOPE
`
`WHEREAS Defendant Samsung Bioepis Co., Ltd. filed an abbreviated biologics Hcense
`
`application seeking FDA approval of SB3 as a trastuzumab biosimilar, which will be marketed
`
`under the brand name Ontruzant®;
`
`WHEREASPlaintiffs Genentech, Inc. and City of Hopefiled a First Amended Complaint
`
`in this case on January 17, 2019, which asserts infringement of twenty-one patents in connection
`
`with Samsung Bioepis seeking FDA approval of SB3 as a trastuzumabbiosimilar (D.I. 63);
`
`WHEREAS Samsung Bioepis has answered the First Amended Complaint and asserted
`
`counterclaims of non-infringement, invalidity, and/or unenforceability with respect to the
`
`twenty-one patents in the First Amended Complaint (D.I. 66);
`
`WHEREAS,on January 14, 2019, Samsung Bioepis filed a letter with the Court stating
`A
`
`WHEREASSamsung Bioepis representsthatitPO
`ee
`
`
`
`
`
`Case 1:18-cv-01363-CFC Document119_Filed 04/29/19 Page 2 of 5 PagelD #: 14069
`
`
`
`WHEREASUSS. Patent No. 6,407,213 will expire on June 18, 2019, and certain other
`
`patents in the First Amended Complaint have expired or will expire on or before June 18, 2019;
`
`NOW THEREFORE,it is hereby stipulated and agreed by the Parties, subject to the
`
`approval of the Court, that:
`
`1.
`
`All claimsfor infringement of U.S, Patent Nos. 6,331,415; 7,923,221; 6,407,213;
`
`6,417,335; 9,249,218; and 6,339,142 (the “Dismissed Patents”) (Counts I, If, HY, EX, X, and XI
`
`of the First Amended Complaint (D.1. 63)) are dismissed without prejudice, and all
`
`counterclaims for non-infringement, invalidity, and/or unenforceability of the Dismissed Patents
`
`(Counts [, I, I, 1V, V, VI, VIL, VIL, XIX, XX, XXI, XX, XXIIand XXIV of Samsung
`
`Bioepis’s Counterclaims (D.I. 66)) are dismissed without prejudice;
`
`2.
`
`3.
`
`City of Hopeis dismissed as a party to this case; and
`
`Eachparty shall! bear its own costs, expenses, and attorneys’ fees associated with
`
`this action with respect to the Dismissed Patents.
`
`This stipulation is solely for the purpose of limiting the scopeof the litigation with
`
`respect to patents that have already expired or will expire on or before June 18,2019. This
`
`+pana
`1s sition doc
`
`not affect the parties’ claims, counterclaims, or defenses with respect to the remaining patents-in-
`
`suit.
`
`This stipulation is expressly conditioned onPO
`
`EE 11:dismissal is without prejudice to
`
`Genentech’s ability to bring a new cause of action with respect to any Dismissed Patentif,
`
`
`
`
`
`
`
`
`
`
`
`Case 1:18-cv-01363-CFC Document 119
`
`Filed 04/29/19
`
`Page 3 of 5 PagelD #: 14070
`
`subsequent tothis stipulation,[I i
`
`/s/ Frederick L. Cottrell, HT
`Frederick L. Cottrell, HI G2555)
`Jason J. Rawnsley (#5379)
`Alexandra M. Ewing (#6407)
`RICHARDS, LAYTON & FINGER, P.A.
`920 North King Street
`Wilmington, DE 19801
`(302) 651-7700
`cottrell@rlf.com
`rawnsley@rlf.com
`ewing@rlf.com
`
`OfCounsel:
`
`William F. Lee
`Lisa J, Pirozzolo
`Emily R. Whelan
`Kevin S. Prussia
`Andrew J. Danford
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`
`60 State Street
`Boston, MA 02109
`(617) 526-6000
`william.lee@wilmerhale.com
`lisa.pirozzolo@wilmerhale.com
`emily.whelan@wilmerhale.com
`kevin.prussia@wilmerhale.com
`andrew.danford@wilmerhale.com
`
`/s/ David E, Moore
`David E. Moore (#3983)
`Bindu A. Palapura (#5370)
`Stephanie E. O’Byrne (#4446)
`Jennifer Penberthy Buckley (#6264)
`POTTER ANDERSON CORROON
`Hercules Plaza, 6th Floor
`1313 N. Market Street
`Wilmington, DE 19801
`Tel: (302) 984-6000
`dmoore@potteranderson.com
`bpalapura@potteranderson.com
`sobyrne@potteranderson.com
`
`OF COUNSEL:
`
`Dimitrios T. Drivas
`Scott T. Weingaertner
`Amit H. Thakore
`Holly Tao
`John P. Padro
`WHITE & CASE LLP
`1221 Avenue of the Americas
`New York, New York 10020-1095
`Tel: (212) 819-8200
`
`Attorneysfor Defendant Samsung Bioepis Co.,
`Ltd.
`
`
`
`Case 1:18-cv-01363-CFC
`
`Document119_
`
`Filed 04/29/19
`
`Page 4 of 5 PagelD #: 14071
`
`Robert J. Gunther Je.
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`robert.gunther@wilmerhale.com
`
`Daralyn J, Durie
`Adam R.Brausa
`DURIE TANGRILLP
`217 LeidesdorffSt.
`San Francisco, CA 94111
`(415) 362-6666
`ddurie@durietangri.com
`abrausa@durietangri.com
`
`Attorneysfor Plaintiffs Genentech, Inc. and
`City ofHope
`
`Dated: April 22, 2019
`
`SO ORDEREDthis
`
`day of
`
`, 2019.
`
`United States District Judge
`
`
`
`
`
`
`
`
`
`Case 1:18-cv-01363-CFC
`
`Document119_
`
`Filed 04/29/19
`
`Page 5 of 5 PagelD #: 14072
`
`CERTIFICATEOFSERVICE
`
`I hereby certify that on April 22, 2019, true and correct copies of the foregoing document were caused
`
`be served on the following counsel in the mannerindicated:
`
`VIA ELECTRONIC MAIL
`David Moore
`Bindu Ann Palapura
`POTTER ANDERSON CORROON LLP
`1313 North Market Street, 6th Floor
`Wilmington, Delaware 19801
`dmoore@potteranderson.com
`bpalapura@potteranderson.com
`
`VIA ELECTRONIC MAIL
`Amit Thakore
`Dimitrios T. Drivas
`Holly Tao
`Scott T, Weingaertner
`John P. Padro
`WHITE & CASE LLP
`1221 Avenue of the Americas
`New York, New York [0020-1095
`athakore@whitecase.com
`ddrivas@whitecase.com
`holly.tao@whitecase.com
`sweingaertner@whitecase.com
`jpadro@whitecase.com
`
`/s/ Jason J. Rawnsley
`Jason J. Rawnsley (#5379)
`rawnsley@rlf.com
`
`
`
`
`